Ocugen, Inc. (NASDAQ:OCGN) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Tiffany Hamilton - Head, Corporate Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Jessica Crespo - Chief Accounting Officer & Senior Vice President, Finance Conference Call Participants Jennifer Kim - Cantor Fitzgerald Robert LeBoyer - Noble Capital Daniil Gataulin - Chardan Jonathan Aschoff - ROTH Capital Partners Uy Ear - Mizuho Securities Operator Good morning and ...

Ocugen, Inc. (NASDAQ:OCGN) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Tiffany Hamilton - Head, Corporate Communications Shankar Musunuri - Chairman, Chief Executive Officer and Co-Founder Jessica Crespo - Chief Accounting Officer and Senior Vice President, Finance Conference Call Participants Jennifer Kim - Cantor Jonathan Aschoff - ROTH Capital Partners Daniil Gataulin - Chardan Robert LeBoyer - Noble Capital Markets Swayampakula Ramakanth - H.C. Wainwright Operator Goo ...

Ocugen, Inc. (NASDAQ:OCGN) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Ken Inchausti - Head, Investor Relations & Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Jessica Crespo - Chief Accounting Officer & Senior Vice President, Finance Conference Call Participants Zegbeh Jallah - ROTH Capital Partners Swayampakula Ramakanth - H.C. Wainwright Operator Good morning, and welcome to the Ocugen Conference Call. At this time, all participants are ...

ocugen. Courageous Innovation April 2022 NASDAQ: OCGN Forward Looking Statement This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as "predicts," "believes," "potential," "proposed," "continue," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should" or other words that convey uncertainty of future even ...

Ocugen, Inc. (NASDAQ:OCGN) Q4 2021 Earnings Conference Call February 25, 2022 8:30 AM ET Company Participants Ken Inchausti - Head of Investor Relations & Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Sanjay Subramanian - Chief Financial Officer & Head of Corporate Development Conference Call Participants Zegbeh Jallah - ROTH Capital Partners Brian Cheng - Cantor Operator Good morning, and welcome to the Ocugen Conference Call. At this time, all participants are in a liste ...

3Q21 Financial Results Conference Call & Webcast November 9, 2021 Introduction Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 relating to preclinical and clinical development of our product candidates, the timing and reporting of results from preclinical studies and clinical trials, the prospects and timing of the potential regulatory approval of our product candidates, commercialization plans, man ...

Ocugen, Inc. (NASDAQ:OCGN) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Shankar Musunuri – CEO Sanjay Subramanian – CFO Ken Inchausti – Head of Investor Relations Conference Call Participants Keay Nakae – Chardan Zegbeh Jallah – Roth Capital Robert Leboyer – Noble Capital Sean Lee – HC Wainwright Operator Good morning, and welcome to the Ocugen Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the present ...

Our Mission is to Develop Gene Therapies to Cure Blindness Diseases and Develop a Vaccine to Save Lives from COVID-19 NASDAQ: OCGN Corporate Deck: August 2021 Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, pro ...

Ocugen Inc. (NASDAQ:OCGN) Q2 2021 Earnings Conference Call August 6, 2021 8:30 AM ET Company Participants Shankar Musunuri - Chairman, Chief Executive Officer Sanjay Subramanian - Chief Financial Officer, Head of Corporate Development Ken Inchausti - Head of Investor Relations and Communications Conference Call Participants Keay Nakae - Chardan Robert LeBoyer - Noble Capital Swayampakula Ramakanth - HC Wainwright Kristen Kluska - Cantor Fitzgerald Operator Good morning and welcome to the Ocugen conference c ...

Our Mission is to Develop Gene Therapies to Cure Blindness Diseases and Develop a Vaccine to Save Lives from COVID-19 NASDAQ: OCGN Corporate Deck: May 2021 Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, produc ...